Inventor
DEMEULE MICHEL
CA21 patents
⚠️ This page may combine multiple inventors who share the name “DEMEULE MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANGIOCHEM INC
4 patentsUS7557182B2Jul 7, 2009
Molecules for transporting a compound across the blood-brain barrier
ANGIOCHEM INC37 citations94
US7902156B2Mar 8, 2011
Aprotinin polypeptides for transporting a compound across the blood-brain barrier
ANGIOCHEM INC21 citations90
US9713646B2Jul 25, 2017
Potentiation of anticancer agents
ANGIOCHEM INC1 citations49
US9687561B2Jun 27, 2017
Peptide-dendrimer conjugates and uses thereof
ANGIOCHEM INC1 citations48
BELIVEAU RICHARD
3 patentsUS8969310B2Mar 3, 2015
Potentiation of anticancer agents
BELIVEAU RICHARD6 citations82
US8487072B2Jul 16, 2013
Compounds for stimulating P-glycoprotein function and uses thereof
BELIVEAU RICHARD12 citations77
US8828949B2Sep 9, 2014
Aprotinin polypeptides for transporting a compound across the blood-brain barrier
BELIVEAU RICHARD1 citations60
CASTAIGNE JEAN-PAUL
3 patentsUS9173891B2Nov 3, 2015
Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
CASTAIGNE JEAN-PAUL6 citations80
US9161988B2Oct 20, 2015
Multimeric peptide conjugates and uses thereof
CASTAIGNE JEAN-PAUL6 citations79
US8921314B2Dec 30, 2014
Conjugates of GLP-1 agonists and uses thereof
CASTAIGNE JEAN-PAUL5 citations69
TRANSFERT PLUS SEC
3 patentsUS11034727B2Jun 15, 2021
Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
TRANSFERT PLUS SEC6 citations78
US11780882B2Oct 10, 2023
Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
TRANSFERT PLUS SEC3 citations67
US12269902B2Apr 8, 2025
Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
TRANSFERT PLUS SEC1 citations58